New therapeutic targets and innovative drug deliveries for pediatric solid tumors

Our aim is to improve existing therapies for pediatric solid tumors and to devise novel therapies, with a particular focus on rhabdomyosarcoma.

The treatment of tumors in children must meet specific needs, as chemotherapeutic agents can lead to significant long-term consequences. It is therefore the aim of our research to optimize existing therapies by targeting them to the tumor, sparing normal tissues and minimizing long-term side effects.

In a friendly and enthusiastic atmosphere, we can also count on collaborations with the DBMR Mass Spectrometry, Flow Cytometry, Life Cell Imaging and Animal Facilities.

Master work projects: if you are interested in performing a master work in one of our projects, please contact

Please visit our Lab Website for more information.